CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (450)	12/9/1999 12:43:00 AM
From: Pseudo Biologist	Read Replies (1) of 666

For NHL, yes they were using Rituxan. But I think they are looking at other cancers and for at least one of those they have their own humanized Ab (and I seem to recall they were trying to make it or a fragment thereof in plants). Sorry for being vague, home page of co. seems to be down and I am too tired now to swim through the SEC stuff. Obligatory Coulter comment: This is a nice post from Yahoo! land; summarizes expected toxicities of different treatments (patient perspective): messages.yahoo.com PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next